Overview

A Trial of SHR7280 in Healthy Subjects

Status:
COMPLETED

Trial end date:
2025-07-05

Target enrollment:

Participant gender:

Summary

The study is being conducted to evaluate the effect of high-fat meal on pharmacokinetics of SHR7280 after oral administration and the effect of SHR7280 on QT interval at low and high doses in healthy Chinese volunteers.

Phase:

PHASE1

Details

Lead Sponsor:

Jiangsu HengRui Medicine Co., Ltd.